School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Lupin Limited LUPIN.NS

Healthcare · Drug Manufacturers - Specialty & Generic

₹1,956last close 2026-10-09 · delayed data

Trailing returns

1M-6.83%
3M-21.28%
6M-14.14%
1Y+0.67%
5Y+112.46%

Basis: Adjusted daily closes.

What it does

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs).

Open LUPIN.NS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies